Your browser doesn't support javascript.
loading
Are Surrogate Endpoints Unbiased Metrics in Clinical Benefit Scores of the ASCO Value Framework?
Cheng, Sierra; Cheung, Matthew C; Jiang, Di Maria; McDonald, Erica; Arciero, Vanessa S; Ezeife, Doreen Anuli; Rahmadian, Amanda; Chambers, Alexandra; Sabarre, Kelley-Anne; Parmar, Ambika; Chan, Kelvin K W.
Afiliação
  • Cheng S; aOdette Cancer Centre, Sunnybrook Health Sciences Centre, and.
  • Cheung MC; aOdette Cancer Centre, Sunnybrook Health Sciences Centre, and.
  • Jiang DM; bDepartment of Medicine, University of Toronto.
  • McDonald E; bDepartment of Medicine, University of Toronto.
  • Arciero VS; aOdette Cancer Centre, Sunnybrook Health Sciences Centre, and.
  • Ezeife DA; aOdette Cancer Centre, Sunnybrook Health Sciences Centre, and.
  • Rahmadian A; bDepartment of Medicine, University of Toronto.
  • Chambers A; aOdette Cancer Centre, Sunnybrook Health Sciences Centre, and.
  • Sabarre KA; cCanadian Agency for Drugs and Technologies in Health; and.
  • Parmar A; cCanadian Agency for Drugs and Technologies in Health; and.
  • Chan KKW; aOdette Cancer Centre, Sunnybrook Health Sciences Centre, and.
J Natl Compr Canc Netw ; 17(12): 1489-1496, 2019 12.
Article em En | MEDLINE | ID: mdl-31805528

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores / Determinação de Ponto Final / Neoplasias / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores / Determinação de Ponto Final / Neoplasias / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article